In an era when cyberattacks evolve at machine speed, this convergence delivers far more than incremental improvements.

Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of ...

Paradigm Biopharmaceuticals Ltd (ASX:PAR) has completed a $14 million placement and launched a share purchase plan (SPP) to ...

By Ahmed Aboulenein WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

The late-stage developer of a drug for knee osteoarthritis, Paradigm Biopharmaceuticals has increased its placement from $8 ...

Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health ...

When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real ...

The first drones intended to stop school shootings from Campus Guardian Angel are set to go live Friday at Deltona High ...

The AICPA and CIMA announced its new "AI Skills Accelerator," an intensive multi-course program that provides a wide breadth ...

L&T Semiconductor Technologies Ltd (LTSCT)), a wholly-owned subsidiary of Larsen & Toubro (L&T), has announced that it is joining the imec ‘Automotive Chiplet Program’ (ACP), a pre-competitive ...

The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting by reviewing ...